Fox Run Management L.L.C. Buys New Shares in Pediatrix Medical Group, Inc. $MD

Key Points

• Fox Run Management L.L.C. acquired a new stake in Pediatrix Medical Group, purchasing 23,783 shares valued at approximately $345,000 in the 1st quarter.
• Several other institutional investors also increased their stakes, with 97.71% of the stock now owned by hedge funds and institutional investors.
• Pediatrix Medical Group reported $0.53 EPS for the last quarter, exceeding expectations, although revenue declined by 7.1% year-over-year, amounting to $468.84 million.

Fox Run Management L.L.C. bought a new stake in shares of Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 23,783 shares of the company's stock, valued at approximately $345,000.

Several other institutional investors and hedge funds also recently bought and sold shares of the stock. California State Teachers Retirement System lifted its position in Pediatrix Medical Group by 0.9% during the fourth quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock valued at $1,054,000 after purchasing an additional 752 shares in the last quarter. SummerHaven Investment Management LLC lifted its position in Pediatrix Medical Group by 0.9% during the first quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock valued at $1,628,000 after purchasing an additional 1,028 shares in the last quarter. Natixis Advisors LLC lifted its position in Pediatrix Medical Group by 8.1% during the first quarter. Natixis Advisors LLC now owns 19,156 shares of the company's stock valued at $278,000 after purchasing an additional 1,435 shares in the last quarter. GAMMA Investing LLC lifted its position in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock valued at $37,000 after purchasing an additional 1,765 shares in the last quarter. Finally, New York State Teachers Retirement System lifted its position in Pediatrix Medical Group by 1.9% during the first quarter. New York State Teachers Retirement System now owns 133,313 shares of the company's stock valued at $1,932,000 after purchasing an additional 2,527 shares in the last quarter. 97.71% of the stock is currently owned by hedge funds and other institutional investors.

Pediatrix Medical Group Price Performance

Shares of Pediatrix Medical Group stock opened at $16.4810 on Wednesday. The stock's 50-day simple moving average is $13.62 and its 200-day simple moving average is $13.88. Pediatrix Medical Group, Inc. has a 52 week low of $10.06 and a 52 week high of $17.67. The company has a market capitalization of $1.44 billion, a price-to-earnings ratio of 12.78 and a beta of 1.21. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last posted its earnings results on Tuesday, August 5th. The company reported $0.53 EPS for the quarter, topping analysts' consensus estimates of $0.42 by $0.11. The company had revenue of $468.84 million for the quarter, compared to the consensus estimate of $464.37 million. Pediatrix Medical Group had a return on equity of 18.94% and a net margin of 5.66%.The firm's revenue for the quarter was down 7.1% on a year-over-year basis. During the same period in the previous year, the business earned $0.34 earnings per share. As a group, analysts expect that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several equities analysts recently weighed in on the company. Macquarie lifted their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Zacks Research upgraded Pediatrix Medical Group to a "strong-buy" rating in a research report on Monday, August 11th. Finally, UBS Group boosted their price objective on Pediatrix Medical Group from $16.00 to $16.50 and gave the company a "neutral" rating in a research report on Thursday, August 14th. One research analyst has rated the stock with a Strong Buy rating, two have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat.com, Pediatrix Medical Group presently has a consensus rating of "Moderate Buy" and a consensus target price of $16.75.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.

Want to see what other hedge funds are holding MD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Pediatrix Medical Group, Inc. (NYSE:MD - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.